Ruijuan graduated from East China Normal University and is a visiting scholar at the University of Houston, USA. She is an expert in bioinformatics, with rich working experience in disease detection and drug development. Currently, she is responsible for the consulting service for drug development-related software at Certara and possesses profound knowledge and experience in utilizing Pinnacle 21 Enterprise (P21E) to ensure data compliance with CDISC standards.